Skip to main content

Table 2 Major adverse cardiac events during follow-up

From: Outcomes and prognostic factors of patients treated for in-stent restenosis: a retrospective single-center experience

Event N (%) Occurrence delay (months) mean/median ± SD [min–max]
Total MACEs 44 (37.9%) 15/17 ± 11.9 [1–51]
Myocardial infarction (MI) 30 (25.9%) 20.5/18 ± 11.9 [2–51]
Target vessel revascularization (TVR) 5 (4.3%) 22.5/24 ± 10.9 [1–51]
Target lesion revascularization (TLR) 24 (20.9%) 20.4/24 ± 11.9 [1–51]
Deaths 11 (9.5%) 22.9/24 ± 10.9 [1–51]
  1. MACEs major adverse cardiac events, max maximum months, min minimum months, SD standard deviation